We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Empowering landlords with the tools they need to efficiently manage the letting process of their properties. Honest Homes aims to cut out intermediaries and instead offers transparent systematic guides via their online platform to save UK landlords and tenants time and money. Their service provides users with abilities to create contracts, ensure compliance and perform monetary transactions for the collection and payment of deposits and rent. Honest Homes' all-in-one solution aims to reduce average landlord admin costs from 12%, to 3%. Their service is designed to be fully automated and includes features such as reviews and ratings for both landlords and tenants. The company is aiming to host 1.8% of UK addresses by their fifth year, which represents around 60k listings and they are also planning to expand their services into Europe.
days to go: Expired investment: £166,670
Ofixu is an online platform that aim to help you with your office requirements. If you have underutilised space then Ofixu will help you earn extra cash by listing it at no extra cost. On the other hand, if you're an entrepreneur looking to rent an office, you can find one local to you by using Ofixu's worldwide search function.
days to go: Expired investment: £151,762
Nutrifix is an app that locates healthy meals nearby or selects recipes or delivery options all tailored to you bodies needs. The app is like having a personal nutritionist in your pocket and is in a growing sector as the global value of mobile health solutions is set to reach 83,000,000,000 by 2022.

Pitch Rated

70%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £194,310
Anastasis Biotec (AB) is a company that is developing a human protein-based product, Syntana-4 (S-4), that inhibits Cancer Stem Cells (CSC) - the growth engine of cancer. The global cancer drug market was at ~$200 billion in 2019. S-4 will initially target use for patients with relapsed prostate cancer which caused 3.8% of global cancer deaths in 2018. The company asserts that S-4 will have low manufacturing costs, making it affordable, enabling ‘mass-market’ sales. AB has raised £450,000 in equity convertible loans and grants in 2019 & 2020, including an Innovate-UK award. It is also aiming to progress S-4 further in collaboration with the University of Chicago’s cancer stem cell therapeutics Research and development (R&D) program. The company will use the investment to complete lab-testing before starting clinical trials.

Pitch Rated

53%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £270,543
Mindful uses blockchain, artificial intelligence (AI) and video technologies to deliver mental health recovery programmes for 8 to 25-year-olds. With the help of their technology, the therapists work with families and schools to change the way of providing mental health services. The company has a powerful management team experience in business, healthcare and education. Mindful is currently running a pilot project and is signing up schools in the West Midlands. The company is signing partnerships with 6 Multi Academy Trusts with further trust to sign > 50 schools.
days to go: Expired investment: £91,850
Bright Salon is a smartphone app that is designed to allow hair and beauty salons grow their business. The app can be used to fill in the gaps from last minute cancellations. The app can also be used as an alternative to paper-based loyalty schemes. Using the app for a loyalty scheme allows customers to see exactly how many points they have and the milestones they have to reach to acheive certain rewards.
days to go: Expired investment: £28,640
My Friends Room allows travellers to rent accommodation from friends and friends of friends. Many vacation rentals can seem unsafe and impersonal. However renting from a friend or someone that has been recommended from a friend prevents this feeling of unsafety.
days to go: Expired investment: £97,870
Ofixu is an online platform that ai mto help you with your office requirements. If you have underutilised space then Ofixu will help you earn extra cash by listing it at no extra cost. On the other hand, if you're an entrepreneur looking to rent an office, you can find one local to you by using Ofixu's worldwide search function. 
days to go: Expired investment: £52,412
Her.9 is a Direct-To-Consumer (DTC) female technology brand that caters to the needs of women during pregnancy. It cites research arguing that up to 40% of women taking prenatal vitamins may not be able to absorb the folic acid within the UK’s leading pregnancy brand. Her.9 aims to resolve this by employing DUOCAP technology. The company asserts that DUOCAP is a capsule-in-capsule delivery system which contains solubilised prebiotics in the outer capsule and probiotics in the inner capsule. The prebiotic releases immediately and the probiotic releases later allowing for targeted supplement delivery in the body. The prenatal supplements market is set to be worth $56 billion globally by 2024. Her.9 aims to be a notable contender in this segment. The company is raising investment to build its already established partnerships and execute its marketing strategy effectively.

Pitch Rated

50%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £215,946
Housebooker offers holiday accommodation in real peoples homes. They provide its clients with a way of generating a significant income through their managed services and aim to achieve a better return for their clients over what they would traditionally get from a buy-to-let. 
days to go: Expired investment: £12,950
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph